Upgrade to SI Premium - Free Trial

Coya Therapeutics receives FDA fast track designation for ALS treatment

May 12, 2026 7:30 AM
Coya Therapeutics, Inc. (NASDAQ: COYA) announced that the U.S. Food and Drug Administration has granted Fast Track Designation for COYA ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA